These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 28586719)

  • 1. A heparin conjugate, LHbisD4, inhibits lymphangiogenesis and attenuates lymph node metastasis by blocking VEGF-C signaling pathway.
    Choi JU; Chung SW; Al-Hilal TA; Alam F; Park J; Mahmud F; Jeong JH; Kim SY; Byun Y
    Biomaterials; 2017 Sep; 139():56-66. PubMed ID: 28586719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sunitinib inhibits lymphatic endothelial cell functions and lymph node metastasis in a breast cancer model through inhibition of vascular endothelial growth factor receptor 3.
    Kodera Y; Katanasaka Y; Kitamura Y; Tsuda H; Nishio K; Tamura T; Koizumi F
    Breast Cancer Res; 2011 Jun; 13(3):R66. PubMed ID: 21693010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting VEGFR-3/-2 signaling pathways with AD0157: a potential strategy against tumor-associated lymphangiogenesis and lymphatic metastases.
    García-Caballero M; Paupert J; Blacher S; Van de Velde M; Quesada AR; Medina MA; Noël A
    J Hematol Oncol; 2017 Jun; 10(1):122. PubMed ID: 28629427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of tumor growth and metastasis by simultaneously blocking vascular endothelial growth factor (VEGF)-A and VEGF-C with a receptor-immunoglobulin fusion protein.
    Zhang D; Li B; Shi J; Zhao L; Zhang X; Wang C; Hou S; Qian W; Kou G; Wang H; Guo Y
    Cancer Res; 2010 Mar; 70(6):2495-503. PubMed ID: 20197464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of lymphangiogenesis in human lymphatic endothelial cells by simultaneously blocking VEGF-C and VEGF-D/VEGFR-3 with norcantharidin.
    Liu ZY; Qiu HO; Yuan XJ; Ni YY; Sun JJ; Jing W; Fan YZ
    Int J Oncol; 2012 Nov; 41(5):1762-72. PubMed ID: 22922710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
    Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
    Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3-O-Acetyloleanolic acid inhibits VEGF-A-induced lymphangiogenesis and lymph node metastasis in an oral cancer sentinel lymph node animal model.
    Hwang-Bo J; Bae MG; Park JH; Chung IS
    BMC Cancer; 2018 Jul; 18(1):714. PubMed ID: 29976150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular control of lymphatic metastasis.
    Achen MG; Stacker SA
    Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant human endostatin endostar inhibits tumor growth and metastasis in a mouse xenograft model of colon cancer.
    Jia Y; Liu M; Huang W; Wang Z; He Y; Wu J; Ren S; Ju Y; Geng R; Li Z
    Pathol Oncol Res; 2012 Apr; 18(2):315-23. PubMed ID: 21938482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor-C secreted by pancreatic cancer cell line promotes lymphatic endothelial cell migration in an in vitro model of tumor lymphangiogenesis.
    Ochi N; Matsuo Y; Sawai H; Yasuda A; Takahashi H; Sato M; Funahashi H; Okada Y; Manabe T
    Pancreas; 2007 May; 34(4):444-51. PubMed ID: 17446844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of lymphangiogenesis and angiogenesis in breast tumor xenografts and lymph nodes by a peptide derived from transmembrane protein 45A.
    Lee E; Koskimaki JE; Pandey NB; Popel AS
    Neoplasia; 2013 Feb; 15(2):112-24. PubMed ID: 23441126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The angiostatic protein 16K human prolactin significantly prevents tumor-induced lymphangiogenesis by affecting lymphatic endothelial cells.
    Kinet V; Castermans K; Herkenne S; Maillard C; Blacher S; Lion M; Noël A; Martial JA; Struman I
    Endocrinology; 2011 Nov; 152(11):4062-71. PubMed ID: 21862622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endostatin inhibits tumour lymphangiogenesis and lymphatic metastasis via cell surface nucleolin on lymphangiogenic endothelial cells.
    Zhuo W; Luo C; Wang X; Song X; Fu Y; Luo Y
    J Pathol; 2010 Nov; 222(3):249-60. PubMed ID: 20814900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lentivirus-mediated small interfering RNA targeting VEGF-C inhibited tumor lymphangiogenesis and growth in breast carcinoma.
    Guo B; Zhang Y; Luo G; Li L; Zhang J
    Anat Rec (Hoboken); 2009 May; 292(5):633-9. PubMed ID: 19382240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct roles of vascular endothelial growth factor-D in lymphangiogenesis and metastasis.
    Kopfstein L; Veikkola T; Djonov VG; Baeriswyl V; Schomber T; Strittmatter K; Stacker SA; Achen MG; Alitalo K; Christofori G
    Am J Pathol; 2007 Apr; 170(4):1348-61. PubMed ID: 17392173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lymphangiogenes and location of tumor lymphatic vessels induced by VEGF-C in primary breast carcer].
    Huang JH; Li Y; Liu L; Yang HC; Hai J; Tang LL; Hu TH
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Feb; 31(1):36-9, 51. PubMed ID: 16562672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intervention of rukangyin on the lymphangiogenesis in breast cancer metastasis nude spontaneous mouse model].
    Li XQ; Dang XG
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Dec; 31(12):1657-61. PubMed ID: 22384554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipopolysaccharide increases the release of VEGF-C that enhances cell motility and promotes lymphangiogenesis and lymphatic metastasis through the TLR4- NF-κB/JNK pathways in colorectal cancer.
    Zhu G; Huang Q; Huang Y; Zheng W; Hua J; Yang S; Zhuang J; Wang J; Ye J
    Oncotarget; 2016 Nov; 7(45):73711-73724. PubMed ID: 27713159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of FLT4 suppresses metastasis of melanoma cells by impaired lymphatic vessels.
    Lee JY; Hong SH; Shin M; Heo HR; Jang IH
    Biochem Biophys Res Commun; 2016 Sep; 478(2):733-8. PubMed ID: 27507214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-VEGF-A therapy reduces lymphatic vessel density and expression of VEGFR-3 in an orthotopic breast tumor model.
    Whitehurst B; Flister MJ; Bagaitkar J; Volk L; Bivens CM; Pickett B; Castro-Rivera E; Brekken RA; Gerard RD; Ran S
    Int J Cancer; 2007 Nov; 121(10):2181-91. PubMed ID: 17597103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.